Breast-sparing surgery after chemotherapy for inflammatory breast cancer
Part of Cancer, Skin clinical trials.
This trial tests whether a breast-conserving surgery (removing only the tumor, not the whole breast) can work well for people with inflammatory breast cancer after their tumors fully disappear with chemotherapy. It aims to help patients avoid a full mastectomy while keeping good cancer control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have inflammatory breast cancer.
- After chemotherapy, the cancer is no longer visible on tests or exams.
- The cancer has not spread to distant parts of the body.
- The cancer is not growing or recurring during treatment.
- You are willing and able to have radiation therapy after surgery, as part of standard care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing if a less invasive sentinel lymph node biopsy can replace more extensive lymph node removal in women with inflammatory breast cancer who have had chemotherapy and whose nodes appear cancer-free. This could help avoid unnecessary side effects.
This trial compares breast-conserving surgery (removing only the tumor and nearby tissue) to total mastectomy (removing the whole breast) for women with breast cancer in the central area of the breast. The goal is to see if the less extensive surgery works just as well.
This trial tests whether some women with HER2-positive breast cancer can safely avoid breast surgery if their tumor nearly disappears after chemotherapy. It uses MRI and biopsy results to find people most likely to have no remaining cancer (pCR).
This study tests whether a less invasive lymph node biopsy is effective for women with inflammatory breast cancer who have finished chemotherapy and are having surgery. It could help doctors know if the cancer has spread to lymph nodes without removing all of them.
This study compares two types of breast-conserving surgery for women who have already had chemotherapy before their operation. It aims to see if using a tiny camera (endoscope) leads to equally good long-term results as standard breast-conserving surgery.
This trial tests whether women with certain aggressive breast cancers (HER2-positive without hormone receptors, or triple-negative) can safely skip breast surgery if chemotherapy makes their tumor completely disappear. The goal is to avoid surgery and its side effects when it may no longer be needed.
Hear when a new Inflammatory Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.